Search clinical trials for: Elagolix Oral Product

Total 10678 results

Medstar Health Research Institute

Active, not recruiting

Myomectomy vs Uterine Artery Embolization vs GnRh Antagonist for AUB-L (Magical)

Fibroid Uterus | Heavy Menstrual Bleeding

United States
University of Southern California

Unknown

Hormonal Effects of the Oral Gonadotropin Releasing Hormone (GnRH) Antagonist at Different Periods of the Menstrual Cycle

Ovulation; Failure or Lack of
Qilu Pharmaceutical (Hainan) Co., Ltd.

Recruiting

A Study to Evaluate Safety and Efficacy of Elagolix in Patients With Moderate to Severe Endometriosis-Associated Pain

Endometriosis

China
AbbVie (prior sponsor, Abbott)
Neurocrine Biosciences

Completed

An Open-label Study of the Effects of Elagolix in Adult Premenopausal Females

Folliculogenesis

United States, Puerto Rico
Nanjing Chia-tai Tianqing Pharmaceutical

Recruiting

A Clinical Trial to Evaluate Efficacy and Safety of Elagolix Tablets in Women With Moderate or Severe Endometriosis-associated Pain

Endometriosis

China
AbbVie

Completed

A Study to Evaluate the Safety and Efficacy of Elagolix for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women

Uterine Fibroids

United States, Puerto Rico
SVR Group

Not yet recruiting

Evaluation of the Efficacy of TOPIALYSE Baume Protect+ on Atopic Dermatis (TOPIAbis)

Atopic Dermatitis
Yale University
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Cardiovascular Disease Risk in Women With Endometriosis

Endometriosis

United States
Instituto do Cancer do Estado de São Paulo

Recruiting

Dose-escalation of Regorafenib in Advanced Hepatocellular Carcinoma (STRAT-aHCC)

Hepatocellular Carcinoma | Liver Cancer

Brazil
UAS Labs LLC

Completed

Effects of Oral Probiotic Product on Vaginal Microbial Community and Parameters of Vaginal Health

Vaginal Health

Canada
St George's, University of London

Recruiting

Lokelma for RAAS Maximisation in CKD & Heart Failure. (LIFT)

Chronic Kidney Diseases | Heart Failure With Reduced Ejection Fraction | Hyperkalemia | ACE Inhibitor Induced Hyperkalaemia | Mineralocorticoid Resistant Hyperkalemia

United Kingdom
AbbVie

Completed

A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain

Endometriosis

United States, Canada, Puerto Rico
University Hospital, Bordeaux

Completed

Evaluation of Effect and Tolerance of the Association of Baricitinib and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo (BARVIT)

Vitiligo

France
AbbVie (prior sponsor, Abbott)

Completed

A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain (ELARIS EM-I)

Endometriosis
AbbVie

Completed

A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain (ELARIS EM-II)

Endometriosis
AbbVie

Active, not recruiting

Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women

Uterine Fibroids | Heavy Menstrual Bleeding

United States, Puerto Rico
Brigham and Women's Hospital

Unknown

Potassium Binder in CKD Patients (With Hyperkalemia) (DiPo Trial)

Chronic Kidney Diseases | Hyperkalemia

United States
Peking Union Medical College Hospital

Unknown

Reducing Elevated Heart Rate in Patients With Severe Sepsis by Ivabradine (REHSI)

Sepsis, Severe
Duke University
Vifor Pharma

Completed

Patiromer Efficacy to Reduce Episodic Hyperkalemia in End Stage Renal Disease Patients

End Stage Renal Disease | Hyperkalemia

United States
Bayer

Terminated

Study to Gather Information How Well Three Different Doses of BAY1817080 Given Twice Daily Over 12 Weeks Work in Comparison to an Inactive Pill (Placebo) and Elagolix in Women Suffering From Pain Related to a Condition Where the Tissue That Usually Grows Inside the Womb Grows Outside of the Womb (SCHUMANN)

Endometriosis

Spain, Belgium, United States, Germany, Austria, Japan, Canada, Hungary, Bulgaria, Italy, China, Czechia, Finland, Norway, Poland, Slovakia, Estonia, Greece, Latvia, Lithuania
Xenon Pharmaceuticals Inc.

Completed

Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Oral Doses of XEN901

Healthy Volunteers

United Kingdom
National Cheng Kung University
National Cheng-Kung University Hospital; Ministry of Science and Technology...

Recruiting

Post-stroke Epilepsy: Primary Prophylaxis Study

Middle Cerebral Artery Stroke

Taiwan
SWOG Cancer Research Network
National Cancer Institute (NCI)

Recruiting

A Study of miRNA 371 in Patients With Germ Cell Tumors

Seminoma | Germ Cell Tumor | Metachronous Malignant Neoplasm | Stage I Testicular Cancer AJCC v8 | Stage IA Testicular Cancer AJCC v8 | Stage IB Testicular Cancer AJCC v8 | Stage IS Testicular Cancer AJCC v8

Canada, United States, Guam
Cukurova University

Completed

Clinical Effects of Bacillus Containing Oral Hygiene Products on Gingivitis: a Randomized Controlled Trial

Gingivitis

Turkey
Institut de Recherche pour le Developpement

Completed

Treatment of Pediculosis (Head Lice) in Senegal (IVERAZITH)

Pediculoses

Senegal
AbbVie

Completed

An Extension Study to Evaluate the Efficacy and Safety of Elagolix in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

Uterine Fibroids | Heavy Menstrual Bleeding

United States, Canada, Puerto Rico
Instituto Nacional de Cancerologia de Mexico

Recruiting

Alectinib Pharmacokinetic in Patients With NSCLC

ALK Gene Mutation | Non-small Cell Lung Cancer Stage IIIB

Mexico
Coloplast A/S

Completed

Investigation of a New Stoma Product for People With a Stoma (CP288)

Peristomal Skin Complication

Norway
Oslo University Hospital

Completed

Effects of Patiromer on Pharmacokinetics of Immunosuppresive Drugs in Renal Transplant Recipients (TACPAT)

Hyperkalemia | Kidney Transplant

Norway
Abbott Nutrition

Withdrawn

Evaluation of a Nutritional Supplement for People With Type 2 Diabetes.

Diabetes

United States
Abbott Nutrition

Completed

Evaluation of a Nutritional Product for People With Type 2 Diabetes

Diabetes

United States
AbbVie

Recruiting

Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain

Endometriosis

United States, Puerto Rico
Pfizer

Terminated

Voxelotor Neurocognitive Function Study

Sickle Cell Disease

United States
Wake Forest University Health Sciences

Completed

A Pilot Trial of Twice-weekly Versus Thrice-weekly Hemodialysis in Patients With Incident End-stage Kidney Disease (TWOPLUS-HD)

End Stage Renal Failure on Dialysis

United States
AbbVie

Completed

Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (Replicate Study)

Uterine Fibroids | Heavy Menstrual Bleeding

United States, Canada
AbbVie

Completed

Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women

Uterine Fibroids | Heavy Menstrual Bleeding

United States, Canada, Puerto Rico
Wake Forest University Health Sciences
Stanford University; University of North Carolina, Chapel Hill

Completed

Elagolix for Fertility Enhancement Clinical Trial (EFFECT)

Endometriosis | Unexplained Infertility

United States
Swedish Match AB

Completed

Controlled Study of the Ability of a Smokefree Tobacco Product to Increase the Quit Rate Among Cigarette Smokers

Cigarette Smoking

United States
University of Calgary
Bayer

Unknown

Upfront Combination Pulmonary Arterial Hypertension Therapy

Pulmonary Hypertension

Canada
University Hospital, Geneva
Danone Research

Completed

Influence of Protein Supplements on Serum Insulin-like Growth Factor-I Levels in Women With Anorexia Nervosa

Anorexia Nervosa

Switzerland
AbbVie

Completed

Efficacy and Safety Study of Elagolix in Women With Endometriosis

Endometriosis, Pain
Capital Health, Canada
Sunnybrook Health Sciences Centre; Erasmus Medical Center; IWK Health Centre; Afexa... and other collaborators

Completed

Use of COLD-fX to Prevent Respiratory Infections in Community Dwelling Seniors

Respiratory Tract Infection

Canada, Netherlands
Lindsey Russell, MD
Napo Pharmaceuticals, Inc.

Not yet recruiting

Open-Label Pilot Study With Crofelemer in Patients With Short Bowel Syndrome

Short Bowel Syndrome

United States
AbbVie

Completed

Elagolix Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of Endometriosis (PETAL)

Endometriosis
University of Wisconsin, Madison

Recruiting

PROMMO Trial: Oral Misoprostol vs IV Oxytocin (PROMMO)

Induction of Labor Affected Fetus / Newborn | Premature Rupture of Membrane

United States
National Cheng-Kung University Hospital

Completed

0.12% Chlorhexidine Oral Care for the Prevention of Non-ventilator Hospital-acquired Pneumonia

Hospital-acquired Pneumonia

Taiwan
University of Chicago
Myovant Sciences GmbH

Recruiting

Surgical Myomectomy Followed by Oral Myfembree Versus Standard of Care Trial (SOUL) (SOUL)

Pelvic Pain | Metrorrhagia | Leiomyoma | Menorrhagia

United States
NorthShore University HealthSystem
Pfizer

Not yet recruiting

Phenotyping of Idiopathic Pelvic Pain With Real-time Uterine Imaging and Relugolix-Combination Therapy Treatment

Pelvic Pain

United States
University of Southampton
University of Nottingham; Norfolk and Norwich University Hospitals NHS Foundation... and other collaborators

Not yet recruiting

Cellulitis Optimal Antibiotic Treatment (COAT)

Cellulitis of Leg
AbbVie

Completed

Study of the Safety and Efficacy of Elagolix in Women With Polycystic Ovary Syndrome

Polycystic Ovary Syndrome

United States, Puerto Rico

3

Subscribe